We believe doing the right thing always makes sound business sense.

We have a responsibility not only to our customers, partners and employees, but also to the environment we inhabit and the communities we serve worldwide.

We work hard every day to reduce our energy demand and carbon emissions, support our communities, and improve access to medicines, vaccines and quality healthcare around the world.

Our goal is to remain in step with the evolving demands of global business - to be competitive, ethical, innovative, and committed to the idea that good citizenship makes good business sense.

In the area of Access to Health, MSD has initiated the following science based partnerships and patient support programs in India:

Certificate Course in Evidence Based Diabetes Management (CCEBDM) :

MSD in India has partnered with Public Health Foundation of India (PHFI) and Dr. Mohan's Diabetes Education Academy (DMDEA) for launch and expansion of CCEBDM (Certificate Course in Evidence Based Diabetes Management) to develop core skills and competencies in primary care physicians for the practice of evidence based diabetes management, focused on the management of Type 2 Diabetes.

An educational grant for this capacity building initiative has been provided by MSD in India. The aim of the program, CCEBDM, is to impart on-job training to the primary care physicians on the latest advances in the field of Diabetes Management. The course curriculum is divided into twelve modules spread over 12 months under which physicians are trained by regional faculty identified by the program organizers. This is the first of its kind program to receive IDF accreditation.

6821 doctors trained on CCEBDM


Listening to and responding to the ‘Voice of the Customer’ (doctors) and the need of India’s patients, MSD in India started a unique patient support program called SPARSH™ in January 2009, which means 'touch' in English. The program, which is offered to patients taking JANUVIA and JANUMET on recommendation of the prescribing physician, offers comprehensive diabetes management, including diet and exercise counseling, education on diabetes and its complications via a call center.

No. of patients enrolled in the life of SPARSH™ - 102917

Antibiotic Stewardship Program (AMS)

The Antibiotic Stewardship Program was initiated by MSD India in the year 2008. Antimicrobial stewardship program (AMS) is an attempt to rationalize the use of antimicrobials in the hospital setup by focusing on treatment guidelines based on local microbiology data of the hospital coupled with established principles of antimicrobial stewardship. The most significant achievement of the project was that it made available to the scientific community a patient/physician friendly format of AMS which can be rolled out in day to day clinical practice at the patient bedside even with basic minimum resources at their disposal.

AMS rolled out in 150 hospitals

MSD for Mothers

MSD for mothers’ is a 10 year $500 million initiative to create a world where no woman dies from complications from pregnancy and child birth.

In India, during Phase I (2013-2016), MSD for Mothers has committed $10 million to innovative partnerships with leading nongovernmental organizations. These partnerships will engage and explore the potential of local private providers and health businesses to strengthen maternal health care. These partnerships are setting out to improve the affordability, accessibility and quality of private maternal health services.


As a global health care company, MSD has an important responsibility to increase access to medicines and vaccines, and a commitment to help reduce the burden of disease around the world. As part of that commitment, the company’s Foundation is supporting a new partnership with Project ECHO® (Extension for Community Healthcare Outcomes) through a US$7 million grant over five years (2017-2021) to expand the replication of Project ECHO® in India and Vietnam and help improve access to specialty care for complex, chronic conditions among underserved populations. This partnership aligns with Sustainable Development Goal (SDG) number three – Good Health and Well-Being – one of 17 SDGs unanimously adopted in 2015 by all the member states of the United Nations. The SDGs represent the greatest global effort to improve the lives of all of the world’s population.

MSD Wellcome Trust Hilleman Laboratories

A first-of-its-kind initiative, Hilleman Laboratories is an equal joint-venture partnership formed between MSD and Wellcome Trust, a global charitable foundation dedicated to human and animal health. Headquartered in India, Hilleman Laboratories is a not-for-profit organization leveraging a cadre of talented scientists from around the globe. The research center is named in honor of Dr. Maurice Ralph Hilleman (1919-2005), the father of modern vaccine science. Through Hilleman Labs, MSD is looking to develop a heat-stable rotavirus vaccine which will help minimize logistics costs for developing countries like India.